170 related articles for article (PubMed ID: 9334360)
1. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P
J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360
[TBL] [Abstract][Full Text] [Related]
2. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.
Irvine KR; Rao JB; Rosenberg SA; Restifo NP
J Immunol; 1996 Jan; 156(1):238-45. PubMed ID: 8598468
[TBL] [Abstract][Full Text] [Related]
3. Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model.
Carroll MW; Overwijk WW; Chamberlain RS; Rosenberg SA; Moss B; Restifo NP
Vaccine; 1997 Mar; 15(4):387-94. PubMed ID: 9141209
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity.
Kim KW; Kim SH; Jang JH; Lee EY; Park SW; Um JH; Lee YJ; Lee CH; Yoon S; Seo SY; Jeong MH; Lee ST; Chung BS; Kang CD
Cancer Immunol Immunother; 2004 Apr; 53(4):315-22. PubMed ID: 14685778
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.
Shinagawa N; Yamazaki K; Tamura Y; Imai A; Kikuchi E; Yokouchi H; Hommura F; Oizumi S; Nishimura M
Cancer Immunol Immunother; 2008 Feb; 57(2):165-74. PubMed ID: 17628800
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells.
Sheng XL; Zhang H
World J Gastroenterol; 2007 Nov; 13(44):5944-50. PubMed ID: 17990361
[TBL] [Abstract][Full Text] [Related]
7. CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo.
He S; Wang L; Wu Y; Li D; Zhang Y
J Exp Clin Cancer Res; 2010 Apr; 29(1):37. PubMed ID: 20420712
[TBL] [Abstract][Full Text] [Related]
8. Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma.
Yasuda T; Kamigaki T; Kawasaki K; Nakamura T; Yamamoto M; Kanemitsu K; Takase S; Kuroda D; Kim Y; Ajiki T; Kuroda Y
Cancer Immunol Immunother; 2007 Jul; 56(7):1025-36. PubMed ID: 17131118
[TBL] [Abstract][Full Text] [Related]
9. RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer.
Kato T; Ueda Y; Kinoh H; Yoneyama Y; Matsunaga A; Komaru A; Harada Y; Suzuki H; Komiya A; Shibata S; Hasegawa M; Hayashi H; Ichikawa T; Yonemitsu Y
Neoplasia; 2010 Nov; 12(11):906-14. PubMed ID: 21076616
[TBL] [Abstract][Full Text] [Related]
10. Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene.
Xie LH; Sin FW; Cheng SC; Cheung YK; Chan KT; Xie Y; Xie Y
Cancer Immunol Immunother; 2008 Jul; 57(7):1029-38. PubMed ID: 18157497
[TBL] [Abstract][Full Text] [Related]
11. DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors.
Lim DS; Kim JH; Lee DS; Yoon CH; Bae YS
Cancer Immunol Immunother; 2007 Nov; 56(11):1817-29. PubMed ID: 17443323
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin induced epigenetic regulation of dendritic cell maturation in association with T cell activation facilitates tumor protective immune response in non-small cell lung cancer (NSCLC).
Mukherjee O; Paul S; Das S; Rakshit S; Shanmugam G; George M; Sarkar K
Pathol Res Pract; 2024 Jan; 253():155004. PubMed ID: 38086291
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells.
Panya A; Thepmalee C; Sawasdee N; Sujjitjoon J; Phanthaphol N; Junking M; Wongkham S; Yenchitsomanus PT
Cancer Immunol Immunother; 2018 Oct; 67(10):1579-1588. PubMed ID: 30056600
[TBL] [Abstract][Full Text] [Related]
14. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo.
Fields RC; Shimizu K; Mulé JJ
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9482-7. PubMed ID: 9689106
[TBL] [Abstract][Full Text] [Related]
15. Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge.
Hermans IF; Daish A; Moroni-Rawson P; Ronchese F
Cancer Immunol Immunother; 1997 Aug; 44(6):341-7. PubMed ID: 9298937
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta insensitive dendritic cells: an efficient vaccine for murine prostate cancer.
Wang FL; Qin WJ; Wen WH; Tian F; Song B; Zhang Q; Lee C; Zhong WD; Guo YL; Wang H
Cancer Immunol Immunother; 2007 Nov; 56(11):1785-93. PubMed ID: 17473921
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses.
Zhou Y; McEarchern JA; Howard E; Pestano G; Salgaller ML; Bosch ML
Cancer Immunol Immunother; 2003 Jul; 52(7):413-22. PubMed ID: 12835918
[TBL] [Abstract][Full Text] [Related]
18. Ethanol inhibits antigen presentation by dendritic cells.
Eken A; Ortiz V; Wands JR
Clin Vaccine Immunol; 2011 Jul; 18(7):1157-66. PubMed ID: 21562114
[TBL] [Abstract][Full Text] [Related]
19. A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer.
Masuda Y; Ito K; Konishi M; Nanba H
Cancer Immunol Immunother; 2010 Oct; 59(10):1531-41. PubMed ID: 20563803
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo.
Mushiake H; Tsunoda T; Nukatsuka M; Shimao K; Fukushima M; Tahara H
Cancer Immunol Immunother; 2005 Feb; 54(2):120-8. PubMed ID: 15592717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
